John D. Furber is a scientist and entrepreneur who has been studying the biology of aging, development, and regeneration for more than 25 years. During this time, he has been piecing together a Network Model of the Systems Biology of Human Aging, which can be seen at https://legendarypharma.com/chartbg.html.He is a frequent contributor at meetings in the fields of aging, mitochondria, autophagy, and oxidative stress. These include Gordon Research Conferences, Cold Spring Harbor Conferences, Ellison Colloquia, Harvard/Glenn Symposia, American Aging Association, Gerontological Society of America, International Society on Aging and Disease, SENS Conferences, Oxygen Club of California World Congresses, and the Bay Area Aging Meetings. From 2000-2011, he served on the Board of Directors of the American Aging Association and was twice elected as VP. He earned a Bachelor degree in Physics and Mathematics from the University of California at Santa Cruz in 1975, and a Master of Science degree in Biological Sciences (Developmental and Molecular Biology) from the University of California at Irvine in 1990, where he advanced to PhD Candidacy. Between degrees, he served the United States Congress as a Technology Policy Analyst in the Congressional Office of Technology Assessment. Currently, he is running Legendary Pharmaceuticals, small pharmaceutical research company that is engaged in the discovery of pharmaceutical drugs and gene therapies able to repair and reverse accumulating molecular damage to subcellular mitochondria, lysosomes, nuclei, and extracellular proteins in order to prevent and treat serious, late-onset diseases commonly associated with aging. Legendary Pharmaceuticals is a privately-held small business. He is a frequent contributor at meetings in the fields of aging, mitochondria, autophagy, and oxidative stress. He served on the Board of Directors of the American Aging Association from 2000 to 2011, and was Vice President in 2008-2009.